GlassScriptPhysician profile
Matthew H Bui
NPI 1578547105
$14,197.64
in general payments reported to CMS, 2019-2025
43 companies · $7,343 in 2025
The $7,343 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,119 · 2020: $449 · 2021: $1,341 · 2022: $1,422 · 2023: $1,063 · 2024: $1,460 · 2025: $7,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,089 · Food and Beverage: $3,778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,089.00 |
| Food and Beverage | $3,777.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,031.10 | 2020-2025 | |
| Abbvie INC. | $1,118.60 | 2019-2025 | Lupron Depot, Botox |
| Pfizer INC. | $755.15 | 2019-2025 | |
| Janssen Biotech, INC. | $694.55 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $599.65 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $368.11 | 2023-2025 | Orgovyx |
| Teleflex LLC | $362.91 | 2021-2025 | Urolift, Barrigel |
| Myovant Sciences INC. | $353.55 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $350.51 | 2019-2022 | |
| Becton, Dickinson and Company | $347.65 | 2024 | Bard Urinary Drainage Bag |
| Bayer Healthcare Pharmaceuticals INC. | $319.08 | 2021-2025 | |
| Blue Earth Diagnostics | $309.62 | 2019-2025 | Posluma |
| Ferring Pharmaceuticals INC. | $214.66 | 2019-2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $209.09 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Urogen Pharma, INC. | $188.80 | 2021-2025 | Jelmyto |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $171.90 | 2021-2025 | Prolaris |
| Coloplast Corp | $156.62 | 2020-2021 | |
| Rochester Medical Corporation | $149.08 | 2022 | |
| Allergan, INC. | $145.22 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $144.51 | 2022-2025 | Pylarify |
| C. R. Bard, INC. & Subsidiaries | $128.77 | 2023-2024 | Bard Urinary Drainage Bag |
| Verity Pharmaceuticals INC. | $127.90 | 2022-2025 | Tlando |
| Telix Pharmaceuticals | $118.36 | 2024-2025 | Illuccix |
| Dornier Medtech America, INC | $102.06 | 2025 | Dornier Medtech |
| Profound Medical Corp. | $88.20 | 2023 | Tulsa-Pro |
| Immunitybio, INC. | $87.82 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $73.12 | 2021-2023 | Lynparza |
| Amgen INC. | $54.99 | 2019 | |
| Abc Home Medical Supply, INC. | $54.19 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $49.40 | 2019-2020 | |
| Laborie Medical Technologies Corp. | $43.06 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Procept Biorobotics Corporation | $40.91 | 2024 | Aquabeam System |
| Boston Scientific Corporation | $32.05 | 2019-2021 | |
| Dentsply Ih Ab | $27.55 | 2025 | Lofric |
| Bioprotect Medical, INC. | $23.38 | 2025 | Bioprotect Balloon Implant System |
| Axonics, INC. | $22.39 | 2022 | |
| Tolmar, INC. | $21.64 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $20.34 | 2020 | |
| Urovant Sciences INC | $20.28 | 2022 | |
| Antares Pharma, INC. | $18.15 | 2022 | |
| Dentsply Ih INC. | $18.05 | 2022 | |
| Travere Therapeutics, INC. | $17.38 | 2019 | |
| Hollister Incorporated | $17.29 | 2024 | Vapro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.